Last update 23 Jan 2025

Adeptio Pharmaceuticals Ltd.

Private Company|
United Kingdom
|
www.adeptioltd.com

Overview

Related

6
Drugs associated with Adeptio Pharmaceuticals Ltd.
ADE-616
Target-
Mechanism-
Active Org.-
Originator Org.
Adeptio LLC
Active Indication-
Inactive Indication
Schizophrenia
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
ADE-514
Target-
Mechanism-
Active Org.-
Originator Org.
Adeptio LLC
Active Indication-
Inactive Indication
Dyskinesias [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
ADE-513
Target-
Mechanism-
Active Org.-
Originator Org.
Adeptio LLC
Active Indication-
Inactive Indication
Dyskinesias [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
6
Clinical Trials associated with Adeptio Pharmaceuticals Ltd.
CTIS2023-509518-12-01
/ RecruitingPhase 2
An Open label, Safety Clinical trial of (+)-a-dihydrotetrabenazine in patients with moderate to severe tardive dyskinesia - ADT-2023-001
CTRI/2023/08/056242
/ CompletedNot Applicable
An open label balanced randomized single dose two treatment two sequence two period crossover oral bioequivalence study of test formulations of test product 1 plus Alpha Dihydrotetrabenazine plus Alpha DHTBZ 15 mg Powder dissolved in apple juice & test product 2 plus Alpha Dihydrotetrabenazine plus Alpha DHTBZ 15 mg administered as Oral Solution 2 mg per mL Adeptio Pharmaceutical Limited UK in healthy adult human male subjects under fasting conditions - Nil
CTRI/2023/05/053234
/ CompletedNot Applicable
An open-label, balanced, single dose, three-treatment, three-period, oral bioavailability study thatcompares test formulations of (+) - Alpha - Dihydrotetrabenazine ({+}-α -DHTBZ) 15 mg powder:Adeptio Pharmaceutical Limited, UK) administered as a single 15 mg dose and also as 7.5 mg twice daily dose against an 80 mg single dose of valbenazine (Test 1= 15 mg powder, Test 2= 7.5 mg powder, Test 3= valbenazine 80 mg capsule) in healthy, adult, human subjects under fasting conditions.
100 Clinical Results associated with Adeptio Pharmaceuticals Ltd.
Login to view more data
0 Patents (Medical) associated with Adeptio Pharmaceuticals Ltd.
Login to view more data
100 Deals associated with Adeptio Pharmaceuticals Ltd.
Login to view more data
100 Translational Medicine associated with Adeptio Pharmaceuticals Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
6
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ADE-513
Movement Disorders
More
Pending
ADE-616
Schizophrenia
More
Pending
Zedeptine
Autoimmune Diseases
More
Pending
ADE-514
Movement Disorders
More
Pending
ADE-615
Schizophrenia
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free